University of California, Berkeley

The University of California, Berkeley, established in 1868, is a leading public research university located on a 1,232-acre campus overlooking the San Francisco Bay. Renowned for its academic rigor and commitment to innovation, UC Berkeley plays a significant role in advancing the economic and social well-being of the Bay Area, California, and the broader nation. The university is home to a diverse academic community that engages in groundbreaking research and fosters public policy discussions. Additionally, UC Berkeley boasts a vibrant athletic program, with the California Golden Bears representing the university in various sports as part of the National Collegiate Athletic Association.

Nancy Olson

Trustee

4 past transactions

XLD Finance

Seed Round in 2022
XLD is a borderless decentralized network that delivers financial services to emerging markets.

ZiO Health

Non Equity Assistance in 2022
ZiO Health is a biotechnology company that has developed proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes. Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care.

Samay

Grant in 2019
COPD will cost $61 billion per year by 2029, but no technologies can evaluate lung function from home, leaving patients and doctors to rely on questionnaires. Samay will disrupt the remote diagnostic market just as Dexcom did with Diabetes and iRhythm with cardiac arrhythmias. Our chest patches use a patented technology that diagnoses COPD with 90% accuracy and detects exacerbation biomarkers with 83% accuracy, passively. We're building an AI-assisted management and diagnostic platform to accompany patients and doctors throughout the care continuum, from exacerbation detection to determining effective therapies for more personalized care, all from home.

DNALite Therapeutics

Seed Round in 2018
DNALite Therapeutics is an early-stage preclinical biotechnology company committed to bringing the next generation of drugs to the gastrointestinal tract. It develops oral lipid nanoparticle technology to deliver mRNA and pDNA into the intestine using the oral route of administration. Its drug aims to use the intestinal tract to secrete proteins into the bloodstream turning any protein biologic into an oral drug.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.